Trial intelligence / Profile preview

Timing of Subcutaneous Tranexamic Acid Injection in Mohs Micrographic Surgery

NCT07807371Not yet recruiting

Sponsor
Cooper University Health Care
Start
Nov 2026
Primary completion
Nov 2028
01

Overview

Trial of tranexamic acid in Postoperative bleeding (2 arms), sponsored by Cooper University Health Care. Primary endpoint: Quantity of bleeding events at 48 hours. Planned start Nov 2026; status: not yet recruiting.

02

Drugs

tranexamic acid
03

Conditions

Postoperative bleeding

Beyond the preview

Go deeper on NCT07807371.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07807371.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call